HomeCompareKMB vs ROL

KMB vs ROL: Dividend Comparison 2026

KMB yields 5.25% · ROL yields 1.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ROL wins by $14.12M in total portfolio value· pulled ahead in Year 4
10 years
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →
ROL
ROL
● Live price
1.38%
Share price
$53.04
Annual div
$0.73
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$14.17M
Annual income
$12,435,164.79
Full ROL calculator →

Portfolio growth — KMB vs ROL

📍 ROL pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKMBROL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KMB + ROL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KMB pays
ROL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
ROL
Annual income on $10K today (after 15% tax)
$116.99/yr
After 10yr DRIP, annual income (after tax)
$10,569,890.07/yr
At 15% tax rate, ROL beats the other by $10,565,451.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KMB + ROL for your $10,000?

KMB: 50%ROL: 50%
100% ROL50/50100% KMB
Portfolio after 10yr
$7.11M
Annual income
$6,220,193.56/yr
Blended yield
87.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ROL right now

KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
ROL
Analyst Ratings
8
Buy
9
Hold
Consensus: Hold
Price Target
$64.00
+20.7% upside vs current
Range: $52.00 — $72.00
Altman Z
10.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KMB buys
0
ROL buys
0
No recent congressional trades found for KMB or ROL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKMBROL
Forward yield5.25%1.38%
Annual dividend / share$5.06$0.73
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR17%100%
Portfolio after 10y$45.9K$14.17M
Annual income after 10y$5,222.34$12,435,164.79
Total dividends collected$21.6K$14.01M
Payment frequencyquarterlyquarterly
SectorConsumer StaplesIndustrials
Analyst consensusHoldHold
Analyst price target$123.00$64.00

Year-by-year: KMB vs ROL ($10,000, DRIP)

YearKMB PortfolioKMB Income/yrROL PortfolioROL Income/yrGap
1$11,314$614.45$10,975$275.26+$339.00KMB
2$12,867$760.19$12,308$564.69+$559.00KMB
3$14,713$945.27$14,353$1,183.69+$360.00KMB
4← crossover$16,924$1,181.90$17,938$2,580.15$1.0KROL
5$19,596$1,486.64$25,221$6,027.23$5.6KROL
6$22,850$1,882.16$42,827$15,839.73$20.0KROL
7$26,849$2,399.80$96,098$50,273.53$69.2KROL
8$31,812$3,083.36$313,681$210,856.41$281.9KROL
9$38,033$3,994.72$1,622,132$1,286,493.33$1.58MROL
10$45,918$5,222.34$14,170,846$12,435,164.79$14.12MROL

KMB vs ROL: Complete Analysis 2026

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →

ROLIndustrials

Rollins, Inc., through its subsidiaries, provides pest and wildlife control services to residential and commercial customers in the United States and internationally. The company offers pest control services to residential properties protecting from common pests, including rodents, insects, and wildlife. It also provides workplace pest control solutions for customers across various end markets, such as healthcare, foodservice, and logistics. In addition, the company offers traditional and baiting termite protection, as well as ancillary services. It serves clients directly, as well as through franchisee operations. Rollins, Inc. was incorporated in 1948 and is headquartered in Atlanta, Georgia.

Full ROL Calculator →
📬

Get this KMB vs ROL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KMB vs SCHDKMB vs JEPIKMB vs OKMB vs KOKMB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.